Related Experiment Video
Updated: Jul 9, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Design and computational evaluation of E-stilbene-bearing 1,3,4-oxadiazole derivatives as potential tyrosinase
Aasia Javed1, Zulfiqar Ali Khan1, Ameer Fawad Zahoor1
1Department of Chemistry, Faculty of Physical Sciences, Government College University Faisalabad Faisalabad-38000 Pakistan zulfiqar.khan@gcuf.edu.pk.
Abstract:
A series of E-stilbene-bearing 1,3,4-oxadiazole derivatives (4a-b and 5a-f) was synthesized via the Mizoroki-Heck reaction and evaluated as inhibitors of tyrosinase, a vital enzyme involved in melanin biosynthesis. The synthesized compounds were structurally confirmed through NMR spectroscopy (1H NMR, 13C NMR), infrared spectroscopy (FT-IR), and mass spectrometry. Nearly all derivatives exhibited inhibitory effects against tyrosinase with IC50 values ranging from 0.32 ± 0.03 µM to 6.28 ± 0.05 µM. Among them, compounds 5d and 5b illustrated the most significant inhibitory activity, with IC50 values of 0.32 ± 0.03 µM and 0.76 ± 0.01 µM, respectively. Molecular docking against tyrosinase (PDB: 2Y9X) revealed strong binding affinities (-10.0 kcal mol-1 and -8.5 kcal mol-1) exceeding those of the standard inhibitors kojic acid and ascorbic acid. Molecular dynamics simulation (100 ns), DFT analysis, and ADMET predictions further supported the stability, reactivity, and favorable pharmacokinetic behavior of the active compounds. These findings indicate that E-stilbene-based 1,3,4-oxadiazole derivatives hold significant potential as promising scaffolds for the development of new tyrosinase inhibitors for potential dermatological and cosmetic applications.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Enzyme Inhibition